鼻用黄芩苷磷脂复合物原位凝胶脑靶向性研究

李楠 叶英杰 杨明 蒋学华 许润春

中国药学杂志 ›› 2011, Vol. 46 ›› Issue (16) : 1254-1257.

PDF(844 KB)
PDF(844 KB)
中国药学杂志 ›› 2011, Vol. 46 ›› Issue (16) : 1254-1257.
论著

鼻用黄芩苷磷脂复合物原位凝胶脑靶向性研究

  • 李楠1,2 ,叶英杰1 ,杨明3 ,蒋学华2*,许润春1
作者信息 +

Evaluation of Brain-Targeting of Nasal Baicalin-Phospholipid Complex in Situ Gel

  • LI Nan1,2,YE Ying-jie1,YANG Ming3,JIANG Xue-hua2*,XU Run-chun1
Author information +
文章历史 +

摘要

目的 研究鼻用黄芩苷磷脂复合物原位凝胶在大鼠体内血液与脑组织中的药物分布,并评价其脑靶向性。方法 大鼠静注黄芩苷磷脂复合物溶液,经鼻分别给予黄芩苷磷脂复合物混悬液和原位凝胶后,采用HPLC分别测定血浆中及脑组织中黄芩苷的浓度。结果 与静注黄芩苷磷脂复合物溶液组相比,鼻用复合物混悬液和原位凝胶组大鼠脑组织中的药物分布显著增加,且原位凝胶组的脑靶向指数高于混悬液组,其嗅区转移率分别为88.8%,79.1%,药物平均滞留时间前者比后者增加近3倍。结论 鼻用黄芩苷磷脂复合物混悬液和原位凝胶具有一定的脑靶向性,而原位凝胶的脑靶向作用强于混悬液。鼻腔给药可作为传统中药成分黄芩苷治疗脑部疾病一种极具优势的给药途径。

Abstract

OBJECTIVE To investigate the distribution of nasal baicalin-phospholipid complex in-situ gel in rat blood and brain tissues and to evaluate its brain targeting effect. METHODS After intravenous administration of baicalin-phospholipid solution,intranasal administration of baicalin phospholipid complex suspension and in-situ gel,respectively,the concentrations of baicalin in rat plasma and brain tissues were determined by HPLC. RESULTS Compared to intravenous baicalin-phospholipid complex solution,the suspension and in-situ gel produced significant increase of drug distribution in brain tissues. The BTI of in- situ gel was higher than that of the suspension,and the olfactory propotion was 88.8% and 79.1%,respectively. The mean residence time (MRT) of the former increased nearly 3 times than the latter. CONCLUSION Baicalin-phospholipid complex suspension and in situ gel can improve the brain targeting,for which the in-situ gel is more excellent than the suspension. The result indicates that intranasal administration of baicalin as a treatment for brain diseases has strong competitive advantage.

关键词

黄芩苷磷脂复合物 / 鼻用原位凝胶 / 脑靶向 / 脑靶向指数 / 嗅区转移率

Key words

baicalin-phospholipid complex / nasal in situ gel / brain targeting index / olfactory propotion

引用本文

导出引用
李楠 叶英杰 杨明 蒋学华 许润春. 鼻用黄芩苷磷脂复合物原位凝胶脑靶向性研究[J]. 中国药学杂志, 2011, 46(16): 1254-1257
LI Nn;YE Ying-jie;YNG Ming;JING Xue-hu;XU Run-chun. Evaluation of Brain-Targeting of Nasal Baicalin-Phospholipid Complex in Situ Gel[J]. Chinese Pharmaceutical Journal, 2011, 46(16): 1254-1257

参考文献


[1] LEE H,YANG L L,WANG C C,et al. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate-and glucose deprivation-induced neuronal death[J]. Brain Res,2003,986(122):103-113.
[2] GONG M T,YU L F,CHEN Q H, et al. Study on oral bioavailability of baicalin in rats[J]. Chin Pharm J(中国药学杂志),2008,43(17):1332-1335.
[3] XU R C,LIN Y J,WU P J,et al. The physical chemistry study on baicalin-phospholipid complex[J]. Chin Tradit Patent Med (中成药),2008,30(6):932-934.
[4] FAROUK M S. Nasal administration of glucagon combined with dimethyl-fl-cyclodextrin:comparison of pharmacokinetics and pharmacodynamics of spray and powder[J]. Int J Pharm,1996,132(27):189-194.
[5] WANG Q,CHEN G S,ZENG S. Pharmacokinetics of gastrodin in rat plasma and CSF after in and iv [J]. Biopharm,2007,341(122):20-25.
[6] ZHANG Q Z,JIANG X G,JIANG W M,et al. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain [J]. Int J Pharm,2004,275(12):85-96.
[7] YANG J P,LIU H J,CHENG S M,et al. Direct transport of VEGF from the nasal cavity to brain [J]. Neurosci Lett,2009,449(29):108-111.
[8] LIU T M,JIANG X H,ZHANG M J,et al. Absorption characteristics of baicalin and baicalein in rat small intestine[J]. Chin Pharm J(中国药学杂志),2006,41(23):1784-1787.
[9] ZHANG L J, XING D M, WANG W,et al. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract[J]. Int J Pharm,2006,323(29):120-125.
[10] CAI Z, HOU S X, YANG Z X, et al. Brain targeting of gastrodin nasal in situ gel[J]. Sichuan Univ(Med Sci Ed)(四川大学学报:医学版) ,2008,39(3):438-440.
[11] ULRIKA W,ELENA P,BJORN J,et al. Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents[J]. Eur J Pharm,2005,24(15):565-573.
PDF(844 KB)

128

Accesses

0

Citation

Detail

段落导航
相关文章

/